Fellowship · Chicago, IL
Sponsored by McGaw Medical Center of Northwestern University
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
The New England journal of medicine · 2022 · 868 citations · William Muller
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
The New England journal of medicine · 2021 · 1,044 citations · Valentina Stosor
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA · 2021 · 739 citations · Valentina Stosor
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers".
Annals of clinical and translational neurology · 2021 · 511 citations · Igor Koralnik
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
BMJ (Clinical research ed.) · 2022 · 544 citations · Jennie H. Kwon
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
Journal of neurology, neurosurgery, and psychiatry · 2021 · 420 citations · Elena Grebenciucova
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
The Lancet. Child & adolescent health · 2023 · 248 citations · William Muller
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
The New England journal of medicine · 2023 · 218 citations · William Muller